文献速递头颈神经CT

定量能谱CT分析在鉴别眼眶淋巴瘤与其他眼眶淋巴增殖性疾病中的作用

Role of Quantitative Spectral CT Analysis for Differentiation of Orbital Lymphoma and Other Orbital Lymphoproliferative Disease.
PubMed 文献 · Eur J Radiol · 2020-10-24

淋巴瘤的碘密度(1.24±0.24 mg/ml)和40-70 keV能谱衰减曲线斜率(2.44±0.51 HU/keV)均显著高于IOID/IgG4-RD(分别为0.83±0.23 mg/ml和1.66±0.47 HU/keV),两参数曲线下面积分别为0.876和0.884。结论认为定量能谱CT参数有助于鉴别。

要点

  • 眼眶淋巴瘤碘密度(1.24±0.24 mg/ml)显著高于IOID/IgG4-RD(0.83±0.23 mg/ml),P=0.001。
  • 淋巴瘤能谱衰减曲线斜率(2.44±0.51 HU/keV)显著高于IOID/IgG4-RD(1.66±0.47 HU/keV),P=0.001。
  • 碘密度阈值1.0 mg/ml和斜率阈值1.99 HU/keV的敏感度、特异度和准确度均为81.8%。

关键影像表现/征象

  • 定性影像特征(边缘、位置、强化方式、颅神经、软组织及骨受累)在两组间无显著差异。
  • 眼眶淋巴瘤的碘密度为1.24±0.24 mg/ml,IOID/IgG4-RD为0.83±0.23 mg/ml。
  • 眼眶淋巴瘤的40-70 keV能谱衰减曲线斜率为2.44±0.51 HU/keV,IOID/IgG4-RD为1.66±0.47 HU/keV。

诊断标准与关键数值

  • 碘密度阈值1.0 mg/ml鉴别淋巴瘤与IOID/IgG4-RD的敏感度、特异度和准确度均为81.8%,曲线下面积0.876(P=0.0003)。
  • 40-70 keV能谱衰减曲线斜率阈值1.99 HU/keV的敏感度、特异度和准确度均为81.8%,曲线下面积0.884(P=0.0002)。

临床应用与阅片要点

  • 对眼眶肿块行增强能谱CT时,可测量碘密度和40-70 keV能谱衰减曲线斜率辅助鉴别淋巴瘤与IOID/IgG4-RD。
  • 碘密度1.0 mg/ml和斜率1.99 HU/keV可作为鉴别参考阈值,敏感度、特异度和准确度均为81.8%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the value of quantitative parameters from spectral computed tomography for the differentiation of orbital lymphoma from other lymphoproliferative disease, including idiopathic orbital inflammatory disease (IOID) and IgG4-related disease (IgG4-RD).

METHODS: Patients with orbital masses who underwent pre-treatment contrast-enhanced spectral CT were enrolled in this retrospective study. The subjects were divided into lymphoma and other orbital lymphoproliferative disease groups. Qualitative imaging features (margin, location, enhancement pattern, cranial nerves, soft tissue, and bone involvement) were reviewed. Quantitative parameters (iodine density and spectral attenuation curve slope) derived from spectral CT were measured.

RESULTS: Eleven patients had orbital lymphoma and 11 had other orbital lymphoproliferative diseases (idiopathic orbital inflammatory disease (IOID), n = 5; IgG4-related disease (IgG4-RD), n = 6). Qualitative analysis showed no significant difference between the two groups. There was significantly higher iodine density in orbital lymphoma (1.24 ± 0.24 mg/ml) than in IOID/IgG4-RD (0.83 ± 0.23 mg/ml; P = 0.001). An iodine density threshold of 1.0 mg/ml gave sensitivity, specificity, and accuracy of 81.8%, with an area under the curve of 0.876 (P = 0.0003). Orbital lymphoma had a significantly higher iodine spectral attenuation curve slope (2.44 ± 0.51 HU/keV) than IOID/IgG4-RD (1.66 ± 0.47 HU/keV; P = 0.001). A threshold of 1.99 HU/keV for the spectral attenuation curve slope of 40-70 keV gave sensitivity, specificity, and accuracy of 81.8%, with an area under the curve of 0.884 (P = 0.0002).

CONCLUSIONS: Quantitative spectral CT parameters can help differentiate orbital lymphoma from other orbital lymphoproliferative disease, with lymphoma having a significantly higher iodine density value and spectral attenuation curve slope than IOID/IgG4-RD.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tunlayadechanont P, Panyaping T, Kaewkerd B, et al. Role of Quantitative Spectral CT Analysis for Differentiation of Orbital Lymphoma and Other Orbital Lymphoproliferative Disease. Eur J Radiol. 2020. PMID: 33130359. doi:10.1016/j.ejrad.2020.109372

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。